A1L30

2-((1-(but-2-yn-1-yl)-1H-pyrazol-4-yl)(cyclopropylmethyl)amino)-5-(4-(dimethylcarbamoyl)-1H-pyrrol-2-yl)thiazole-4-carboxamide

Created:	2024-08-23
Last modified:	2025-04-02

Find Related PDB Entry
1 entries where A1L30 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	0
Bond Count	60
Aromatic Bond Count	15

2D diagram of A1L30

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-((1-(but-2-yn-1-yl)-1H-pyrazol-4-yl)(cyclopropylmethyl)amino)-5-(4-(dimethylcarbamoyl)-1H-pyrrol-2-yl)thiazole-4-carboxamide
Systematic Name (OpenEye OEToolkits)	2-[(1-but-2-ynylpyrazol-4-yl)-(cyclopropylmethyl)amino]-5-[4-(dimethylcarbamoyl)-1~{H}-pyrrol-2-yl]-1,3-thiazole-4-carboxamide
Formula	C₂₂ H₂₅ N₇ O₂ S
Molecular Weight	451.545
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CC#CCn1cc(cn1)N(CC2CC2)c3sc(c4[nH]cc(c4)C(=O)N(C)C)c(n3)C(N)=O
SMILES	OpenEye OEToolkits	2.0.7	CC#CCn1cc(cn1)N(CC2CC2)c3nc(c(s3)c4cc(c[nH]4)C(=O)N(C)C)C(=O)N
Canonical SMILES	CACTVS	3.385	CC#CCn1cc(cn1)N(CC2CC2)c3sc(c4[nH]cc(c4)C(=O)N(C)C)c(n3)C(N)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC#CCn1cc(cn1)N(CC2CC2)c3nc(c(s3)c4cc(c[nH]4)C(=O)N(C)C)C(=O)N
InChI	InChI	1.06	InChI=1S/C22H25N7O2S/c1-4-5-8-28-13-16(11-25-28)29(12-14-6-7-14)22-26-18(20(23)30)19(32-22)17-9-15(10-24-17)21(31)27(2)3/h9-11,13-14,24H,6-8,12H2,1-3H3,(H2,23,30)
InChIKey	InChI	1.06	HACYEVIDLDLIII-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	171636958

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.